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Introduction
Increased production of reactive oxygen species (ROS) and/or impaired antioxidant defence systems lead to oxidative stress 1,2 and tissue injury. 3 Oxidative stress plays an important role in the pathogenesis of many human diseases. 4 Cells have developed enzymatic (superoxide dismutase [SOD] , catalase [CAT], glutathione peroxidase [GPx], glutathione reductase [GR]) and nonenzymatic (vitamins C, E, A, glutathione) antioxidant defence systems against ROS. One of the ¢rst consequences of oxidative stress is the oxidation of membrane lipids, a chain reaction known as lipid peroxidation (LPO) which causes a loss of membrane £uidity, disrupting membrane integrity and functions. 5 Chain breaking antioxidants such as vitamins A and E can prevent the damage caused by LPO, but advanced LPO may deplete the cellular antioxidants, dramatically reducing the cell's antioxidant capacity. 6 Coeliac disease is an autoimmune disorder provoked by wheat gluten and related proteins from other grains (barley or rye). Gluten causes activation of TH 1lymphocytes and up-regulation of g-interferon 7 in genetically predisposed individuals. These mechanisms lead to an in£ammation of intestinal mucosa. The clinical presentation of coeliac disease is extremely heterogeneous, 8--10 ranging from asymptomatic cases to severe malabsorption of micro-and macronutrients, with a variety of conditions, including diarrhoea, constipation, £atulence, weight loss, vitamin and mineral de¢ciencies, iron de¢ciency anaemia and bone disease. 11, 12 Coeliac disease is one of the few disorders for which the sole treatment is a speci¢c diet. Persons a¡ected by coeliac disease must adhere to a strict gluten-free diet (GFD) permanently, which usually allows the intestinal mucosa to heal, resolves gastrointestinal symptoms and prevents complications that may occur if the disease remains untreated.
Previous data 13--15 suggested that cellular redox status is also implicated in the pathogenesis of coeliac disease. It has been reported that gluten induces a redox imbalance in the intestinal mucosa, probably due to the overproduction of free radicals. 16, 17 In order to examine the alteration of the biochemical response to oxidative stress in untreated and treated coeliac disease, we measured the activities of antioxidant enzymes copper, zinc SOD, CAT, GPx and GR, as well as the concentrations of total glutathione (GSH) and lipid hydroperoxides (LOOH) in peripheral blood of children with di¡erent forms of the disease.
Materials and methods

Subjects
Peripheral blood samples from 39 paediatric coeliac patients were included in the study. The diagnosis of coeliac disease was based on the revised criteria of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. 18 The blood samples were collected on the day of the intestinal biopsy.
In 29 patients intestinal biopsy was performed after the optimal gluten challenge. Children were taking 2--4 slices of wheat bread daily and the duration of the challenge depended on the time of appearance of clinical symptoms such as diarrhoea, £atulence and loss of appetite. In 18 patients the symptoms appeared 10--35 days (median 18) after introducing gluten into the diet (active group) and the challenge was interrupted immediately after. For 11 children, the gluten challenge lasted for a period of four months and during that period they remained free of symptoms (silent group). Typical villous atrophy was found on examination of intestinal biopsy specimens in all patients on gluten containing diet.
The remaining 10 patients had been subjected to GFD for 2--4 years. These children (GFD group) completely recovered during the diet and analysis of their biopsy specimens revealed normal intestinal mucosa.
In addition, blood samples from 30 healthy agematched children were used as control samples. Patients and control subjects were not taking antioxidant medications. Clinical characteristics of control subjects and patients are given in Table 1 .
The Medical Ethical Committee of the University Clinical Centre of Belgrade approved the study. The parents of all patients included in the study gave written informed consent.
Sample preparation
Peripheral blood samples were collected in the morning, in tubes containing lithium heparin as anticoagulant, and divided into aliquots for each assay. For the measurement of SOD activity, the blood was centrifuged at 2500 g, 41C for 5 min (Eppendorf centrifuge 5417, Eppendorf AG, Hamburg, Germany) to separate the plasma. The blood cells were drawn from the bottom, washed three times in cold saline and haemolysed by adding four packed-cell volumes of ice-cold demineralized ultra pure water (MilliQ reagent grade water system, Millipore Corp., Bedford, MA, USA). Ethanol-chloroform extraction was performed to remove haemoglobin interference. Extracts were stored at À701C for later analysis. For the measurement of CAT, GPx, GR and LPO activities, the blood was centrifuged at 1000 g, 41C for 15 min. The plasma was stored at À701C for the LPO assay and the bu¡y coat was discarded. The blood cells were washed three times in cold saline and then lysed in 20 packed-cell volumes of icecold water. Lysates were centrifuged at 8500 g 41C for 10 min to remove the blood cell stroma and supernatants were stored at À701C. For the GSH assay, the whole blood was frozen at À701C.
All assays were performed using a Perkin Elmer Lambda 25 Spectrophotometer (Perkin Elmer Instruments, Norwalk, CT, USA).
The speci¢c enzyme activities of SOD and CAT were expressed as kilounits per gram of haemoglobin (kU/g Hb) and of GPx and GR as milliunits per gram of haemoglobin (mU/g Hb). Concentrations of LOOH and GSH were expressed in micromoles per litre.
SOD assay
SOD activity was measured using the Oxis Bioxytech s sod-525t Assay (Oxis International, Inc., Portland, OR, USA). The method is based on the SOD-mediated increase in the rate of autoxidation of the reagent 1 (5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenzo[c]£uorene) in aqueous alkaline solution, yielding a chromophore with maximum absorbance at 525 nm. Interference due to mercaptans is prevented by pretreating the samples with reagent 2 (1,4,6-trimethyl-2vinylpyridinium). After the addition of R1, the kinetic measurement of the change in the absorbance at 525 nm is performed. One SOD-525 activity unit is de¢ned as the activity that doubles the autoxidation rate of the control blank. The precision of the assay was estimated by the manufacturer as 7.3%.
CAT assay
CAT activity was determined according to the method of Beutler, 19 which is based on the measurement of the rate of H 2 O 2 decomposition by CAT from the examined samples. The decomposition of H 2 O 2 was demonstrated by a decrease in absorbance at 230 nm as a function of time. One CAT activity unit is de¢ned as1 mmol of H 2 O 2 decomposed per minute under the assay conditions.
GPx assay
GPx activity was determined by the Oxis Bioxytech s GPx-340t Assay (Oxis International, Inc., Portland, OR, USA). Upon reduction of an organic peroxide by GPx, oxidized glutathione (GSSG) is produced and its recycling to GSH by GR is accompanied by oxidation of nicotinamide adenine dinucleotide phosphate (NADPH) to NADP þ . The rate of NADPH oxidation, followed by a decrease in absorbance at 340 nm as a function of time, is directly proportional to the GPx activity in the sample. One GPx-340 activity unit is de¢ned as 1 mmol of NADPH consumed per minute under the assay conditions. The precision of the assay was estimated by the manufacturer as 4%.
GR assay
The activity of GR was measured by the Oxis Bioxytech s GR-340t Assay (Oxis International, Inc., Portland, OR, USA). The assay is based on the oxidation of NADPH to NADP þ by GR from the sample. The rate of NADPH oxidation was determined by the rate of the decrease in absorbance at 340 nm. One GR-340 unit is de¢ned as 1 mmol of NADPH oxidized per minute under the assay conditions. The precision of the assay was estimated by the manufacturer as 7.8%.
GSH assay
The concentration of GSH was determined by the Oxis Bioxytech s GSH-420t Assay (Oxis International, Inc., Portland, OR, USA). The method is based on the formation of a chromophoric thione. The reaction is performed in three steps. The sample was ¢rst bu¡ered and treated with a reducing agent (tris(2-carboxyethyl) phosphine) to reduce any GSSG present in the sample. Then the chromogen (4-chloro-1-methyl-7-tri£uoromethylquinolinium methylsulphate) was added, forming thioethers with all thiols in the sample. After a base was added to raise the pH over 13, a b-elimination speci¢c to the GSH-thioether results in the chromophoric thione. The absorbance at 420 nm is directly proportional to the GSH concentration. The precision of the assay was estimated by the manufacturer as 6.1%.
LPO assay
The concentration of LOOH was determined by the Oxis Bioxytech s LPO-560t Assay (Oxis International, Inc., Portland, OR, USA). The assay is based on the oxidation of ferrous to ferric ions by LOOH from the sample under acidic conditions. Ferric ions bind with the indicator dye (xylenol orange), forming a stable coloured complex. The absorbance at 560 nm is directly proportional to the LOOH concentration. To eliminate H 2 O 2 interference, the samples were pre-treated with CAT. The precision of the assay was estimated by the manufacturer as 2.4%.
Statistics
All samples were assayed in triplicate and di¡erences between groups were tested by analysis of variance with repeated measures. Comparisons between patient groups and the control group were performed by Dunnett's test, comparisons among patient groups were by Bonferroni test. Correlations between the activities of antioxidant enzymes or GSH concentration and the concentration of lipid peroxides were evaluated by Pearson's product moment correlation. A P value lower than 0.05 was considered signi¢cant.
Results
The activities of SOD, CAT, GPx and GR are shown in Figure 1 . Only GR activity did not di¡er signi¢cantly between the patient groups and the controls. The three other analysed enzymes showed signi¢cant di¡erences: SOD: Concentrations of GSH and LOOH are shown in Figure 2 . Both GSH and LOOH concentrations varied Statistically signi¢cant relationships were found between GPx activity, GSH and LOOH concentrations ( Figure 3 ). Concentration of LOOH negatively correlated with GPx activity (r ¼ À0.32, Po0.01) and GSH concentration (r ¼ À0.70, Po0.001). A considerable positive correlation was found between GPx activity and the concentration of GSH (r ¼ 0.57, Po0.001).
Discussion
There is a growing body of evidence that ROS are involved in the pathology of many diseases, including a number of gastrointestinal disorders. 20 Increased production of oxygen-derived free radicals 14 as well as pro-oxidative e¡ects of gluten have also been reported in patients with coeliac disease. 21 In this study we found a small signi¢cant increase of SOD activity in patients with active coeliac disease and CAT activity in patients on a GFD. These may represent a physiological response to a higher rate of ROS production. Even though pro-oxidative processes are counteracted by these antioxidant enzymes, increased plasma concentrations of LOOH indicate that this protection is not adequate in active coeliac disease. Increased LPO of plasma chylomicrons and low-density lipoproteins in a patient with coeliac disease has been reported in vitro. 22 In this study, we found an increase of over 40% in plasma concentrations of LOOH in active and silent coeliac patients, whereas in GFD patients concentrations were not signi¢cantly di¡erent to values observed in controls. Elevated LOOH might shift the cellular pro-oxidant/antioxidant balance, thus a¡ecting cell proliferation, di¡erentiation or apoptotic responses and disrupting tissue homoeostasis. 23 This may, in part, explain the increased risk of malignancy, observed in untreated coeliac patients.
The glutathione redox cycle is a crucial determinant of tissue susceptibility to damage by lipid peroxides. 24, 25 Enzyme GPx eliminates formed lipid peroxides using GSH as a reducing agent, which is then regenerated by GR with simultaneous oxidation of NADPH. In the present study, a substantial decrease in GPx activity, as well as in GSH concentrations, is obvious in all patient groups. Since the activity of GPx depends on the availability of GSH and selenium, their depletion may signi¢cantly reduce the antioxidant capacity of the cell. Signi¢cant inverse relationships between the concentrations of LOOH and GSH or the activity of GPx further underline these ¢ndings. On the other hand, GPx activity positively correlated with the GSH concentration. Decreased activities of GSHrelated enzymes in enterocytes from intestinal biopsies with villous atrophy, as well as in erythrocytes of paediatric patients with coeliac disease 26, 27 have been reported. In vitro studies by Dol¢ni et al. 28 showed that gliadin peptides provoked a signi¢cant decrease in cell GSH content and the activities of GSH-related enzymes. Furthermore, lowered serum selenium concentrations have been found in patients with coeliac disease, 29, 30 which may also in£uence the activity of GPx.
GSH is one of the most important cellular nonenzymatic antioxidants. 31 In addition to acting as an enzyme cofactor, GSH can react directly with free radicals and it also plays an important role in recycling chain breaking antioxidants, such as vitamin E and carotenoids 32, 33 which are found to be decreased in treated coeliac patients. 17 Similarly to previous reports, 15, 17, 34 our results show that oxidative stress is strongly associated with coeliac disease and we suggest that it may be an important factor in the pathogenesis of the disease. Changes in the activities of antioxidant enzymes, as well as elevated LOOH, are obvious in the peripheral blood of coeliac patients. Depletion of GSH and decreased GPx activity signi¢cantly reduced antioxidant capacity of these patients, as demonstrated by the increased concentrations of plasma LOOH. These results are in accordance with the ¢ndings of Rivabene et al., 15 who reported an increased concentration of LOOH and a decreased concentration of reduced GSH provoked by wheat gliadin in an in vitro study. In our work the pro-oxidant/antioxidant balance improved substantially in patients on GFD, since in this group the LOOH concentration is only slightly elevated. On the other hand, as changes in antioxidant enzyme activities and GSH content occurred not only in active or silent, but also in GFD patients, it appears that the absence of clinical symptoms and mucosal lesion does not correlate entirely with pro-oxidant/antioxidant balance. Therefore we suggest that antioxidant enzymes and GSH might be important additional parameters in the evaluation of the e¡ectiveness of GFD.
